Crossmark

Long-term outcomes of two first-generation trabecular micro-bypass stents (iStent) with phacoemulsification in primary open-angle glaucoma: eight-year results

Crossref DOI link: https://doi.org/10.1186/s40662-021-00263-1

Published Online: 2021-11-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salimi, Ali http://orcid.org/0000-0003-0016-3478
Watt, Harrison

Harasymowycz, Paul
License Information

Text and Data Mining valid from 2021-11-16

Version of Record valid from 2021-11-16
More Information

Article History

Received: 2 May 2021

Accepted: 11 October 2021

First Online: 16 November 2021

Declarations

:

: All procedures were performed in accordance with the tenets of the Declaration of Helsinki. The study was approved by Ethics Committee of the Hôpital Maisonneuve-Rosemont (Montreal, Canada) and was exempted from patient consent due to its retrospective nature.

: All named authors met the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work in its entirety, and have given their approval for this version to be published.

: Paul Harasymowycz is a consultant for Allergan, Alcon, Glaukos, Ivantis, J and J Vision, Santen, Novartis, and Bausch and Lomb. Ali Salimi and Harrison Watt have nothing to disclose.

Document is current

Any future updates will be listed below